The Institute of Bioengineering and Nanotechnology (IBN) was established in 2003. IBN contributed significantly to the development of Singapore research capabilities through scientific breakthroughs and innovations. The Institute established numerous industrial, clinical and academic collaborations and 13 spin-off companies to commercialize its technologies. It also played an important role in nurturing future research talents through its Youth Research Program.

IBN will continue to capitalize on its multidisciplinary research approach to develop new technologies and products for diagnostics and therapeutics, such as novel nanomedicines, unique biomaterials and systems, tissue and organoid models, and the new research area, xenobiology.